4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-16-088355
Director sold 22,086 shares at $11.18 ($247,008)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SHANNON TIMOTHY M Director | 2016-11-29 | Sale | −22,086 | $11.18 | $247,008 | 3,244,381 | I: show line 1 in the form |
| Open-market sales · 22,086 sh · avg $11.18 · $247,008 | |||||||
Loading xslF345X03/doc1.xml…